Çocukluk Çağında Hemanjiomlar ve Klinik Özellikleri

Yıl 2006, Cilt: 4 Sayı: 3, 63 - 68, 01.09.2006

Betül Sevinir

Öz

Hemanjiomlar çocukluk çağında en sık görülen benign tümörlerdir. Vasküler endotel hücrelerinin çoğalması ile ortaya çıkarlar. Çocuk hekimleri, dermatologlar, pratisyen hekimler, çocuk cerrahları, plastik ve rekonstrüktif cerrahlar, oftalmologlar hemanjiomlu çocuklarla sık sık karşılaşmaktadır. Sık görülmelerine karşılık günlük pratikte farklı lezyonlar bu isimle anılmakta ve tanı karmaşası sürmektedir. Bazı riskli gruplarda doğru klinik yaklaşım için hemanjiomların temel özellikleri ele alınmıştır

Kaynakça

• 1. Smolinski KN, Yan AC. Hemangiomas of Infancy: Clinical and biological characteristics. Clin Pediatr 2005; 44:747-66.
• 2. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003; 48:477-96.
• 3. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: Current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas. Ped Dermatol 2005; 22:383-406.
• 4. Esterly NB. Hemangiomas. In: Harper J, Oranje A, Prose N (eds). Texbook of Pediatric Dermatology. 1st edition. Slovenia. Blackwell Science Ltd; 2002.p. 997-1017.
• 5. Buckmiller LM. Update on hemangiomas and vascular malformations. Curr Opin Otolaryngol Head Neck Surg. 2004; 12:476-87.
• 6. Gampper TJ, Morgan RF. Vascular anomalies-Hemangiomas. Plast Reconstr Surg 2002; 110:572-85.
• 7. Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: An extradiagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 2005; 58:348-52.
• 8. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol 1997; 13:375-423.
• 9. Powell J. Update on hemangiomas and vascular malformations. Curr Opin Pediatr 1999 Oct; 11(5):457-63.
• 11. Metry DW, Haggstrom AN, Drolet BA , et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 2006; 140:975-86.
• 12. Ceisler EJ, Santos L, Blei F. Periorbital hemangiomas: what every physician should know. Pediatr Dermatol 2004; 21:1-9.
• 13. Schwartz SR, Blei F, Ceisler E, et al. Risk factors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. J AAPOS 2006; 10:262-8.
• 14. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment. Pediatrics 2006; 118:882-7.
• 15. Albright AL, Gartner JC, Wiener ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989; 83:977-80.
• 16. Prokurat A, Kluge P, Chrupek M, et al. Hemangioma of the liver in children: Proliferating vascular tumor or congenital vascular malformation? Med Pediatr Oncol 2002; 39:4524-9.
• 17. Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Eng J Med 2000; 343:185-9.
• 18. Maguiness S, Guenter L. Kasabach-Merritt Syndrome. J Cutan Med Sur 2002; 6:335-9.
• 19. Burrows PA, Dubois J, Kassarjian A. Pediatric hepatic vascular anomalies. Pediatr Radiol 2001; 31:533-45.
• 20. Mazoer E Enjolras O, Laurian C, et al Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haem 2000; 24:243-51.
• 21. Frevel T, Rabe H, Ückert F, Harms E. Giant cavenous haemangioma with Kasabach-Meritt syndrome:a case report and review.Eur J Pediatr 2002; 161:43-246.
• 22. Hesselmann S, Micke O, Marquardt T, et al. Kasabach-Merritt syndrome: a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha. Br J Radiol 2002; 75:180-4.
• 23. Enjolras O, Riche MC,Merland JJ, et al. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990; 85:491-8.
• 24. Brasanac D, Janic D, Boricic I, et al. Retroperitoneal kaposiform hemangioendothelioma with tufted angioma-like features in an infant with Kasabach-Merritt syndrome. Pathol Int 2003 Sep; 53:627-31.
• 25. Deb G, Jenkner A, De Sio L, et al. Spindle cell (Kaposiform) hemangioendothelioma with Kasabach-Merritt syndrome in an infant: successful treatment with alpha-2A interferon. Med Pediatr Oncol 1997; 28:358-61.
• 26. Wananukul S, Nuchprayoon I, Seksarn P. Treatment of KasabachMerritt syndrome : a stepwise regimen of prednisolone , dipyridamole and interferon. Int J Dermatol 2003; 42:741-8.
• 27. Moore J, Lee M, Garzon M, et al. Effective therapy of a vascular tumor of infancy with vincristine. J Pediatr Surg 2001; 36:1273-6.
• 28. Fledelius HC, Illum N, Jensen H, Prause JU. Interferon-alfa treatment of facial infantile haemangiomas with emphasis on the sightthreatening varieties. A clinical series. Acta Ophthalmol Scand 2001; 79:370-3.
• 29. Michaud AP, Bauman NM, Burke DK, et al. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 2004; 114:1231-6.